Immune-mediated processes in neurodegeneration: where do we stand?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Neurology

• Publication date

  2016-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00415-016-8052-0PMID 26872669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basophils in inflammation.

  2016cited by this paper
• Immune attack: the role of inflammation in Alzheimer disease

  2015cited by this paper
• Drug permeation across the blood-brain barrier: applications of nanotechnology.

  2015influential reference
• Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.

  2015cited by this paper
• Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases

  2015influential reference
• Anatomy and physiology of the blood-brain barrier.

  2015cited by this paper
• In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis

  2015cited by this paper
• Role of gamma‐delta (γδ) T cells in autoimmunity

  2015cited by this paper
• Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology

  2015cited by this paper
• Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10–Dependent Mechanism

  2015cited by this paper
• Elusive roles for reactive astrocytes in neurodegenerative diseases

  2015cited by this paper
• Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.

  2014cited by this paper
• Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis

  2014cited by this paper
• Toll-Like Receptors 2, -3 and -4 Prime Microglia but not Astrocytes Across Central Nervous System Regions for ATP-Dependent Interleukin-1β Release

  2014cited by this paper
• Mast cells, glia and neuroinflammation: partners in crime?

  2014cited by this paper
• Oligodendrogenesis in the normal and pathological central nervous system

  2014cited by this paper
• Neurodegeneration by Activation of the Microglial Complement–Phagosome Pathway

  2014cited by this paper
• Impact of Inflammatory Cytokines on Effector and Memory CD8+ T Cells

  2014cited by this paper
• RIG-1 receptor expression in the pathology of Alzheimer’s disease

  2014cited by this paper
• Th17 Cells in Autoimmune and Infectious Diseases

  2014cited by this paper
• T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases

  2014influential reference
• Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases.

  2014influential reference
• Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase

  2014cited by this paper
• Regulation of an Autoimmune Model for Multiple Sclerosis in Th2-Biased GATA3 Transgenic Mice

  2014cited by this paper
• The Complement System in Inflammatory Bowel Disease

  2014cited by this paper
• Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

  2014cited by this paper
• Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection

  2014cited by this paper
• Innate immune activation in neurodegenerative disease

  2014influential reference
• Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases

  2014cited by this paper
• Autoimmune Manifestations in the 3xTg-AD Model of Alzheimer's Disease

  2014cited by this paper
• Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges

  2013cited by this paper
• CD8+ T cells in multiple sclerosis

  2013cited by this paper
• P268S in NOD2 associates with susceptibility to Parkinson’s disease in Chinese population

  2013cited by this paper
• Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?

  2013cited by this paper
• Eosinophil recruitment and activation: the role of lipid mediators

  2013cited by this paper
• Parkinson disease: from pathology to molecular disease mechanisms.

  2013cited by this paper
• Basophils and allergic inflammation.

  2013cited by this paper
• Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.

  2013cited by this paper
• Pericyte loss influences Alzheimer-like neurodegeneration in mice

  2013cited by this paper
• Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology

  2013cited by this paper
• Neuron-microglia interaction in neuroinflammation.

  2013cited by this paper
• Targeting eosinophils in allergy, inflammation and beyond

  2013cited by this paper
• Current and Future Therapies for Multiple Sclerosis

  2013cited by this paper
• Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

  2013cited by this paper
• Immune system alterations in amyotrophic lateral sclerosis

  2013cited by this paper
• Eosinophil-Derived Neurotoxin Is Elevated in Patients with Amyotrophic Lateral Sclerosis

  2013cited by this paper
• of amyotrophic lateral sclerosis

  2013cited by this paper
• Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats

  2013cited by this paper
• Innate immunity in the CNS: redefining the relationship between the CNS and Its environment.

  2013influential reference
• Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.

  2013cited by this paper
• The Survival of Memory CD8 T Cells That Is Mediated by IL-15 Correlates with Sustained Protection Against Malaria

  2013influential reference
• Advances in distinguishing natural from induced Foxp3(+) regulatory T cells.

  2013cited by this paper
• Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood

  2012cited by this paper
• Immune Tolerance by Induced Regulatory T Cells in Asthma

  2012cited by this paper
• Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.

  2012cited by this paper
• Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms

  2012cited by this paper
• Heterogeneity of cortical lesions in multiple sclerosis

  2012cited by this paper
• CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy

  2012cited by this paper
• B cell exchange across the blood-brain barrier in multiple sclerosis.

  2012cited by this paper
• Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation

  2012cited by this paper
• Toll-like receptor (TLR) and inflammasome actions in the central nervous system.

  2012cited by this paper
• The Role of Mast Cells in the Defence against Pathogens

  2012cited by this paper
• Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide

  2012cited by this paper
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

  2012cited by this paper
• CD4+T Cells: Differentiation and Functions

  2012cited by this paper
• Signaling in innate immunity and inflammation.

  2012cited by this paper
• NALP1/NLRP1 Genetic Variants are Associated With Alzheimer Disease

  2012cited by this paper
• Amyotrophic lateral sclerosis.

  2012cited by this paper
• NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice

  2012cited by this paper
• How do immune cells overcome the blood–brain barrier in multiple sclerosis?

  2011cited by this paper
• Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood.

  2011cited by this paper
• CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease

  2011cited by this paper
• RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity

  2011cited by this paper
• Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke

  2011cited by this paper
• In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

  2011cited by this paper
• The role of antigen presenting cells in multiple sclerosis.

  2011cited by this paper
• Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.

  2011cited by this paper
• IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain

  2011cited by this paper
• Type 1 regulatory T cells (Tr1) in autoimmunity.

  2011cited by this paper
• Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

  2011cited by this paper
• Glial Cells in Amyotrophic Lateral Sclerosis

  2011cited by this paper
• Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis

  2011cited by this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cited by this paper
• Pericytes regulate the blood–brain barrier

  2010cited by this paper
• The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines.

  2010cited by this paper
• YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

  2010cited by this paper
• Eosinophils in innate immunity: an evolving story

  2010cited by this paper
• IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients

  2010cited by this paper
• Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application

  2010cited by this paper
• Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

  2010cited by this paper
• Neutrophils: Cinderella of innate immune system.

  2010influential reference
• Pattern recognition receptors and inflammation.

  2010influential reference
• Mast cell-orchestrated immunity to pathogens

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Astrocytes and therapeutics for Parkinson’s disease

  2010cited by this paper
• Pericytes: blood-brain barrier safeguards against neurodegeneration?

  2010cited by this paper
• Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot.

  2010cited by this paper
• CD200R1 Agonist Attenuates Mechanisms of Chronic Disease in a Murine Model of Multiple Sclerosis

  2010cited by this paper
• Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease

  2010cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper

• Immunity in Parkinson's disease - The role of innate responses.

  2025cites this paper
• The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer’s Disease

  2025cites this paper
• Biofilm Biology to Brain Health: Harnessing Microbial Wisdom to Uncover Amyloid Dissociating Bifunctional Nano Chaperones for Alzheimer's Therapeutics.

  2025cites this paper
• Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models

  2023cites this paper
• Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine

  2023cites this paper
• Therapeutic Potential of Microbiota Modulation in Alzheimer’s Disease: A Review of Preclinical Studies

  2023cites this paper
• Novel patients with NHLRC2 variants expand the phenotypic spectrum of FINCA disease

  2023cites this paper
• Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases.

  2023cites this paper
• Systemic inflammatory markers in patients with polyneuropathies

  2023cites this paper
• Gcm counteracts Toll-induced inflammation and impacts hemocyte number through cholinergic signaling

  2023cites this paper
• Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities

  2023cites this paper
• Pathogen-derived peptides in drug targeting and its therapeutic approach.

  2022cites this paper
• The role of microRNAs in neurodegenerative diseases: a review

  2022cites this paper
• Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease

  2022cites this paper
• The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases

  2022cites this paper
• Targeting TGF-ß in the Central Nervous System: Assessment of Cynomolgus Monkey—Toxicity and Pharmacokinetics for an LNA-Antisense Oligonucleotide

  2022cites this paper
• ATP-binding cassette transporters and neurodegenerative diseases.

  2021cites this paper
• From the low-density lipoprotein receptor–related protein 1 to neuropathic pain: a potentially novel target

  2021cites this paper
• The Air We Breathe: Air Pollution as a Prevalent Proinflammatory Stimulus Contributing to Neurodegeneration

  2021cites this paper
• Epigenetic Modulation of Microglia Function and Phenotypes in Neurodegenerative Diseases

  2021cites this paper
• Fractionated low-dose radiation induces long-lasting inflammatory responses in the hippocampal stem cell niche.

  2021cites this paper
• Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases

  2021cites this paper
• The Selective Loss of Purkinje Cells Induces Specific Peripheral Immune Alterations

  2021cites this paper
• Kynurenine pathway metabolites selectively associate with impaired associative memory function in depression

  2020cites this paper
• Microglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis

  2020cites this paper
• Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease.

  2020cites this paper
• Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease

  2019cites this paper
• Melatonin and neurodegeneration: From neurotoxic environment to cell resilience

  2019cites this paper
• HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease

  2019cites this paper
• Long‐term immunosuppression for CNS mouse xenotransplantation: Effects on nigrostriatal neurodegeneration and neuroprotective carotid body cell therapy

  2018cites this paper
• A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant

  2018cites this paper
• Deconvolution of the immune landscape of cancer transcriptomics data, its relationship to patient survival and tumour subtypes

  2018cites this paper
• Immunization with α‐synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic Parkinsonism model

  2018influential citation
• Is Triclosan a neurotoxic agent?

  2017cites this paper
• Apitherapy: Therapeutic Effects of Propolis on Neurological Disorders

  2017cites this paper
• Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy

  2017cites this paper
• The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma

  2017cites this paper
• Effect of VEGF on neuronal degeneration and interaction between Alzheimer's disease biomarkers.

  2017cites this paper
• HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort.

  2017cites this paper
• D ifferent Molecular Targets and Its Significant Role in Alzheimer’s Disease: A Review

  year unknowncites this paper